Gap Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Gap Inc trades at $20.75 (market cap $7.55B), while State Street SPDR S&P Biotech ETF trades at $158.26. The key difference: Gap Inc pays a 3.34% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Gap Inc nearer its low. Which is the better fit depends on your goals.
| GAP | XBI | |
|---|---|---|
Market Cap | $7.55B | — |
Sector | Consumer Cyclical | Broad Market / Factor |
52-Week High | $29.13 | $164.28 |
52-Week Low | $18.35 | $86.92 |
Enterprise Value | $10.63B | — |
Dividend Yield | 3.34% | — |
Trailing returns across standard periods
Gap retails apparel, accessories, and personal-care products under the Gap, Old Navy, Banana Republic, and Athleta brands. Old Navy generates more than half of Gap's sales. The firm also operates e-commerce sites, outlet stores, and specialty stores under various Gap names. Gap operates nearly 3,000 stores in North America, Europe, and Asia and franchises about 600 stores in Asia, Europe, Latin America, and other regions. Gap was founded in 1969 and is based in San Francisco.
Read more on GAP →XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →